TARA GILLESPIE: Open Payments
NPI 1346618220 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 54 payments from 11 companies in 2025. Trend: 2023 $887 · 2024 $1,159 · 2025 $1,176
Food & beverage: $1,005Education: $171
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $270 |
| ABBVIE INC. | 18 | $253 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $241 |
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
| Amgen Inc. | 5 | $90 |
| LEO Pharma Inc. | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| UCB, Inc. | 2 | $36 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Sotyktu, OTEZLA, DUPIXENT, ANZUPGO, NEMLUVIO.
Industry payments across KS — which companies pay providers there.
